CYP3A5 EXPRESSION IN HUMAN ENTEROCYTES

被引：0
|
作者：
JANARDAN, SK [1 ]
LOWN, KS [1 ]
GHOSH, M [1 ]
KOLARS, JC [1 ]
WATKINS, PB [1 ]
机构：
[1] UNIV MICHIGAN,DEPT MED,ANN ARBOR,MI 48109
来源：
GASTROENTEROLOGY | 1994年 / 106卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A241 / A241
页数：1
相关论文
共 50 条
  • [1] Selective expression of CYP3A5 and not CYP3A4 in human blood
    Janardan, SK
    Lown, KS
    SchmiedlinRen, P
    Thummel, KE
    Watkins, PB
    PHARMACOGENETICS, 1996, 6 (05): : 379 - 385
  • [2] Expression and localization of CYP3A4 and CYP3A5 in human lung
    Anttila, S
    Hukkanen, J
    Hakkola, J
    Stjernvall, T
    Beaune, P
    Edwards, RJ
    Boobis, AR
    Pelkonen, O
    Raunio, H
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 16 (03) : 242 - 249
  • [3] Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue
    Kivisto, KT
    Bookjans, G
    Fromm, MF
    Griese, EU
    Munzel, P
    Kroemer, HK
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (03) : 387 - 389
  • [4] CYP3A5 Genotype-Phenotype Analysis in the Human Kidney Reveals a Strong Site-Specific Expression of CYP3A5 in the Proximal Tubule in Carriers of the CYP3A5*1 Allele
    Bolbrinker, Juliane
    Seeberg, Stefanie
    Schostak, Martin
    Kempkensteffen, Carsten
    Baelde, Hans
    de Heer, Emile
    Kreutz, Reinhold
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (04) : 639 - 641
  • [5] Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes
    Dennison, Jennifer B.
    Jones, David R.
    Renbarger, Jamie L.
    Hall, Stephen D.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (02): : 553 - 563
  • [6] Statin regulation of CYP3A4 and CYP3A5 expression
    Vieira Willrich, Maria Alice
    Hirata, Mario Hiroyuki
    Crespo Hirata, Rosario Dominguez
    PHARMACOGENOMICS, 2009, 10 (06) : 1017 - 1024
  • [7] Characterization of androgen-regulated expression of CYP3A5 in human prostate
    Moilanen, Anne-Mari
    Hakkola, Jukka
    Vaarala, Markku H.
    Kauppila, Saila
    Hirvikoski, Pasi
    Vuoristo, Jussi T.
    Edwards, Robert J.
    Paavonen, Timo K.
    CARCINOGENESIS, 2007, 28 (05) : 916 - 921
  • [8] Effect of CYP3A5 genotype on the relationship between hepatic CYP3A activity and CYP3A4 and CYP3A5 mRNA expression
    Kolwankar, D
    Ho, H
    Ethell, B
    Vuppalanchi, R
    Marri, SR
    Wrighton, SA
    Jones, DR
    Hall, SD
    DRUG METABOLISM REVIEWS, 2004, 36 : 118 - 118
  • [9] Analysis of genotype, MRNA and protein expression of CYP3A4 and CYP3A5 in human liver
    Czerwinski, M
    Lyon, K
    Mudra, D
    Madan, A
    van Schaik, R
    Gaedigk, A
    Parkinson, A
    DRUG METABOLISM REVIEWS, 2002, 34 : 149 - 149
  • [10] A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression system
    Lee, Su-Jun
    van der Heiden, Ilse P.
    Goldstein, Joyce A.
    van Schaik, Ron H. N.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (01) : 67 - 71
12345